DTB challenges first-line use of certain anti-hypertensives

摘要

First-line use of angiotensin converting enzyme inhibitors or angiotensin-II receptor antagonists in patients with type 2 diabetes who also have microalbuminuria has been called into question by the Drug and Tlierapeutks Bulletin.DTB suggests there is only limited evidence to support this approach,pointing out that most patients with type 2 diabetes and high blood pressure will require combination drug treatment."This will usually include an ACE inhibitor or angiotensin-II receptor antagonist," the review concludes (2005;43:41).LJ Hypnotherapy The June issue of DTB also considers the limitations of hypnotherapy for gastrointestinal disorders (ibid,p45).